Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4Phase NA 3Phase 4 3Phase 3 3Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Smoking Cessation 3Tobacco Use Cessation 1Pain 1Neoplasms 1Agnosia 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 37Zoledronic Acid 34Letrozole 34Sodium Chloride 33Carboplatin 33Bupivacaine 31Bevacizumab 31Docetaxel 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Gemcitabine 22Oxaliplatin 21Morphine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Varenicline × Clear all
NCT02162849 2026-02-09

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

M.D. Anderson Cancer Center

Phase 4 Active not recruiting
204 enrolled

Smoking Cessation, Tobacco Use Cessation

NCT06218823 2025-10-27

Tobacco Treatment Comparison for Cancer Care

University of Wisconsin, Madison

Phase 4 Completed
52 enrolled 9 charts

Neoplasms, Smoking Cessation

NCT06029907 2025-09-04

Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.

Duke University

Phase 4 Completed
19 enrolled

Agnosia, Pain, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡